Rhonda Gass
Known title: DirectorCIK: 0001560682
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Flowers Foods faces recall and BNP Paribas downgrade. Flowers Foods is navigating an allergen recall that may impact its 'Better For You' brand image. Compounding this, BNP Paribas maintained an Underperform rating and lowered its price target to $5. The stock currently trades near its 52-week low, reflecting these ongoing challenges.
Transaction History
| WPC | ▲ Buy | Grant | 469 | $30K | 10/1/2026 | View on chart |
| WPC | ▲ Buy | Grant | 2,824 | $0 | 7/1/2026 | View on chart |
| WPC | ▲ Buy | Grant | 423 | $30K | 7/1/2026 | View on chart |
| WPC | ▲ Buy | Grant | 396 | $27K | 4/1/2026 | View on chart |
| FLO | ▲ Buy | Option Exercise | 6,099 | $0 | 2/15/2026 | View on chart |
| FLO | ▲ Buy | Option Exercise | 4,223 | $0 | 2/15/2026 | View on chart |
| WPC | ▲ Buy | Grant | 423 | $27K | 1/2/2026 | View on chart |
| WPC | ▲ Buy | Grant | 401 | $27K | 10/1/2025 | View on chart |
| WPC | ▲ Buy | Grant | 2,778 | $0 | 7/1/2025 | View on chart |
| WPC | ▲ Buy | Grant | 436 | $27K | 7/1/2025 | View on chart |
| WPC | ▲ Buy | Grant | 436 | $27K | 4/1/2025 | View on chart |
| FLO | ▲ Buy | Option Exercise | 2,465 | $0 | 2/15/2025 | View on chart |
| FLO | ▲ Buy | Option Exercise | 6,713 | $0 | 2/15/2025 | View on chart |
| WPC | ▲ Buy | Grant | 506 | $27K | 1/2/2025 | View on chart |
| FLO | ▲ Buy | Option Exercise | 2,221 | $0 | 12/31/2024 | View on chart |
| WPC | ▲ Buy | Grant | 448 | $27K | 10/1/2024 | View on chart |
| WPC | ▲ Buy | Grant | 503 | $27K | 7/1/2024 | View on chart |
| WPC | ▲ Buy | Grant | 3,203 | $0 | 7/1/2024 | View on chart |
| WPC | ▲ Buy | Grant | 497 | $27K | 4/5/2024 | View on chart |
| WPC | ▲ Buy | Grant | 780 | $0 | 4/1/2024 | View on chart |
| FLO | ▲ Buy | Option Exercise | 2,548 | $0 | 2/15/2024 | View on chart |
| FLO | ▲ Buy | Option Exercise | 6,270 | $0 | 2/15/2024 | View on chart |
| FLO | ▲ Buy | Option Exercise | 3,479 | $100K | 1/1/2024 | View on chart |
| FLO | ▲ Buy | Option Exercise | 2,987 | $0 | 2/15/2023 | View on chart |
| FLO | ▲ Buy | Option Exercise | 6,337 | $0 | 2/15/2023 | View on chart |
| FLO | ▲ Buy | Option Exercise | 7,253 | $0 | 8/20/2022 | View on chart |
| FLO | ▲ Buy | Option Exercise | 2,864 | $0 | 2/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
W. P. Carey Stock Recovers After Office Exit, Dividend Focus
W. P. Carey shares have returned to pre-exit levels, with holders seeing a 21% gain including net lease operating properties. Recent coverage highlights the company's 5.14% dividend yield, positioning it as a stable income option within the REIT sector. This recovery aligns with a broader trend of REITs ending a recent slide, supported by analyst targets averaging $77.93.
W. P. Carey Stock Recovers After Office Exit, Dividend Focus. W. P. Carey shares have returned to pre-exit levels, with holders seeing a 21% gain including net lease operating properties. Recent coverage highlights the company's 5.14% dividend yield, positioning it as a stable income option within the REIT sector. This recovery aligns with a broader trend of REITs ending a recent slide, supported by analyst targets averaging $77.93.